Online citations, reference lists, and bibliographies.
← Back to Search

The Smart Drug Delivery System And Its Clinical Potential

Dong Liu, F. Yang, Fei Xiong, N. Gu
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
With the unprecedented progresses of biomedical nanotechnology during the past few decades, conventional drug delivery systems (DDSs) have been involved into smart DDSs with stimuli-responsive characteristics. Benefiting from the response to specific internal or external triggers, those well-defined nanoplatforms can increase the drug targeting efficacy, in the meantime, reduce side effects/toxicities of payloads, which are key factors for improving patient compliance. In academic field, variety of smart DDSs have been abundantly demonstrated for various intriguing systems, such as stimuli-responsive polymeric nanoparticles, liposomes, metals/metal oxides, and exosomes. However, these nanoplatforms are lack of standardized manufacturing method, toxicity assessment experience, and clear relevance between the pre-clinical and clinical studies, resulting in the huge difficulties to obtain regulatory and ethics approval. Therefore, such relatively complex stimulus-sensitive nano-DDSs are not currently approved for clinical use. In this review, we highlight the recent advances of smart nanoplatforms for targeting drug delivery. Furthermore, the clinical translation obstacles faced by these smart nanoplatforms have been reviewed and discussed. We also present the future directions and perspectives of stimuli-sensitive DDS in clinical applications.
This paper references
10.1016/j.biomaterials.2011.05.047
Self-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomas.
Hung-Wei Yang (2011)
10.1016/j.ijpharm.2011.02.005
PEGylated thermo-sensitive poly(amidoamine) dendritic drug delivery systems.
Y. Zhao (2011)
10.1002/CHIN.201227268
The Golden Age: Gold Nanoparticles for Biomedicine
Erik C Dreaden (2012)
10.1016/j.jconrel.2010.08.027
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
F. Danhier (2010)
10.1016/j.jconrel.2007.12.017
A review of stimuli-responsive nanocarriers for drug and gene delivery.
Srinivas Ganta (2008)
10.1039/c5nr02730f
Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
Seonmi Baek (2015)
10.1016/j.jconrel.2009.12.002
Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance.
M. de Smet (2010)
10.1186/bcr432
Liposome-based drug delivery in breast cancer treatment
J. Park (2002)
10.1016/J.CES.2014.06.042
Smart Nanoparticles for Drug Delivery: Boundaries and Opportunities.
Byung Kook Lee (2015)
10.1016/j.jconrel.2011.11.021
Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery.
S. M. van Dommelen (2012)
10.1039/C4RA10631H
Smart functional polymers – a new route towards creating a sustainable environment
V. Ganesh (2014)
10.1021/nn204240b
Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery.
Xian-Zhu Yang (2012)
10.1016/j.biotechadv.2013.11.009
pH-sensitive nano-systems for drug delivery in cancer therapy.
J. Liu (2014)
10.1016/j.jconrel.2011.06.006
Ultrasound-mediated intracellular drug delivery using microbubbles and temperature-sensitive liposomes.
A. Yudina (2011)
10.1016/j.nano.2012.05.013
The big picture on nanomedicine: the state of investigational and approved nanomedicine products.
M. Etheridge (2013)
10.1016/j.addr.2011.03.010
Stimuli-responsive LbL capsules and nanoshells for drug delivery.
M. Delcea (2011)
10.1002/adma.201300929
Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy.
J. Wang (2013)
10.1021/cr200027j
Organization of glucose-responsive systems and their properties.
Q. Wu (2011)
10.1016/S0022-2836(65)80093-6
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
Mesoporous silica nanoparticles for intracellular controlled drug
JL Vivero‐Escoto (1952)
10.1016/j.jconrel.2014.12.030
Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.
A. Wicki (2015)
10.1002/chem.201400148
Enzyme-responsive intracellular-controlled release using silica mesoporous nanoparticles capped with ε-poly-L-lysine.
L. Mondragón (2014)
10.1021/acsnano.5b04378
Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers.
J. Paris (2015)
10.1016/j.biomaterials.2014.03.046
pH-responsive polymer-liposomes for intracellular drug delivery and tumor extracellular matrix switched-on targeted cancer therapy.
Yi-Ting Chiang (2014)
10.2147/IJN.S26766
Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy
Hsin-I Chang (2012)
10.7150/thno.3464
Applications of Magnetic Microbubbles for Theranostics
Xiaowei Cai (2012)
10.1016/j.jconrel.2009.10.023
Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo.
Y. Obata (2010)
10.1039/c1nr11188d
Gold nanoparticles: preparation, properties, and applications in bionanotechnology.
Yi-Cheun Yeh (2012)
10.1016/j.biomaterials.2009.12.007
Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres.
W. Lu (2010)
10.1016/J.JCONREL.2007.10.009
Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release.
L. Lindner (2008)
10.1016/j.addr.2012.01.002
Enzyme-responsive nanoparticles for drug release and diagnostics.
R. de la Rica (2012)
10.1002/anie.201004133
Enzyme-mediated controlled release systems by anchoring peptide sequences on mesoporous silica supports.
C. Coll (2011)
10.1002/adma.201201498
Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery.
Ran Mo (2012)
10.1016/j.jconrel.2011.02.031
Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles.
R. Liu (2011)
10.1021/nn300291r
Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity.
Z. Chen (2012)
10.1016/S0928-0987(03)00164-7
Smart and genetically engineered biomaterials and drug delivery systems.
J. Kopeček (2003)
10.1002/adma.201200653
Hybrid nanoparticles for detection and treatment of cancer.
M. Sailor (2012)
10.1016/j.addr.2012.06.014
Exosomes as nano-theranostic delivery platforms for gene therapy.
A. Tan (2013)
10.1002/anie.200907210
A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery.
Jin-Zhi Du (2010)
10.1039/c0an00144a
Upconversion nanoparticles in biological labeling, imaging, and therapy.
Feng Wang (2010)
10.1021/MA902714P
Thermoresponsive PS-b-PNIPAM-b-PS Micelles: Aggregation Behavior, Segmental Dynamics, and Thermal Response
J. Adelsberger (2010)
10.1002/anie.201100884
Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells.
Kejin Zhou (2011)
10.3109/02652048.2011.646330
Trigger release liposome systems: local and remote controlled delivery?
Sagida Bibi (2012)
Secretory phospholipase A2 responsive liposomes
G Zhu (2011)
10.1016/j.biomaterials.2010.09.069
Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy.
Chao Wang (2011)
10.1039/C5RA05484B
On demand delivery of ionic drugs from electro-responsive CNT hybrid films
M. Curcio (2015)
10.1111/jth.12321
Thrombus‐targeted perfluorocarbon‐containing liposomal bubbles for enhancement of ultrasonic thrombolysis: in vitro and in vivo study
K. Hagisawa (2013)
10.1002/adma.201301890
Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging.
Zhenjiang Zhang (2013)
10.1021/nn400630x
Injectable nano-network for glucose-mediated insulin delivery.
Z. Gu (2013)
10.7150/thno.10694
Nano-Enabled SERS Reporting Photosensitizers
A. Farhadi (2015)
10.1016/j.biopha.2008.10.001
A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors.
Q. Zhang (2009)
10.1002/adma.201405757
A novel magnetic hydrogel with aligned magnetic colloidal assemblies showing controllable enhancement of magnetothermal effect in the presence of alternating magnetic field.
K. Hu (2015)
10.1016/j.addr.2012.07.002
Exosomes are endogenous nanoparticles that can deliver biological information between cells.
D. Sun (2013)
10.1002/ADMA.201303233
25th anniversary article: Rational design and applications of hydrogels in regenerative medicine.
Nasim Annabi (2014)
10.1021/acsami.5b02210
Controlled drug release and hydrolysis mechanism of polymer-magnetic nanoparticle composite.
F. Yang (2015)
10.1038/nnano.2011.112
Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment.
G. Mikhaylov (2011)
10.1016/j.biomaterials.2009.03.051
Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging.
F. Yang (2009)
10.1007/s40843-015-0059-9
Altering the response of intracellular reactive oxygen to magnetic nanoparticles using ultrasound and microbubbles
F. Yang (2015)
10.1016/j.jconrel.2015.07.030
Using exosomes, naturally-equipped nanocarriers, for drug delivery.
E. Batrakova (2015)
10.1038/nmat2859
Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.
D. S. Wilson (2010)
10.1002/adma.201202367
A hydrogen peroxide-responsive O₂ nanogenerator for ultrasound and magnetic-resonance dual modality imaging.
F. Yang (2012)
10.1016/j.phrs.2010.01.009
Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds.
Pilar Rivera Gil (2010)
10.1039/B509097K
Applications of hybrid organic–inorganic nanocomposites
C. Sanchez (2005)
10.1038/nrc3206
Mouse models of cancer: does the strain matter?
K. Hunter (2012)
10.1007/978-1-60327-360-2_7
Ultrasound-responsive liposomes.
Shao-ling Huang (2010)
10.1016/j.ijpharm.2015.09.022
On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier.
H. Li (2015)
10.1016/j.colsurfb.2009.09.001
Biodegradable polymeric nanoparticles based drug delivery systems.
A. Kumari (2010)
10.1021/nn4010796
Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram.
X. Duan (2013)
10.1007/s00280-012-2042-4
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
J. Silverman (2012)
10.7150/thno.5860
Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
K. Hayashi (2013)
10.1039/C3PY01192E
Redox-responsive polymers for drug delivery: from molecular design to applications
Meng Huo (2014)
10.1002/adma.201103521
Facile synthesis of monodisperse superparamagnetic Fe3O4 Core@hybrid@Au shell nanocomposite for bimodal imaging and photothermal therapy.
Wen-jie Dong (2011)
10.1016/j.biomaterials.2013.10.011
Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds.
Tian-meng Sun (2014)
10.1016/S1357-4310(99)01615-9
Causes and consequences of tumour acidity and implications for treatment.
M. Stubbs (2000)
10.1038/nbt876
Small-scale systems for in vivo drug delivery
David A. LaVan (2003)
10.1002/smll.201000173
Bubble microreactors triggered by an alternating magnetic field as diagnostic and therapeutic delivery devices.
F. Yang (2010)
10.1002/adma.201502003
Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial Infarction.
Mary M Nguyen (2015)
10.1016/j.biomaterials.2012.12.051
Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity.
Yu Wan (2013)
10.1021/nn200007z
Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.
F. Wang (2011)
10.1016/j.biomaterials.2013.01.084
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
R. Cheng (2013)
10.1021/mp3005885
Multifunctional gold nanoparticles for diagnosis and therapy of disease.
A. Mieszawska (2013)
10.1096/fj.10-0503
From “Banghasomes” to liposomes: A memoir of Alec Bangham, 1921–2010
D. Deamer (2010)
10.1002/adma.201501803
Therapeutic Enzyme-Responsive Nanoparticles for Targeted Delivery and Accumulation in Tumors.
Cassandra E Callmann (2015)
10.1002/smll.200901789
Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Juan L Vivero-Escoto (2010)
10.7150/thno.4847
Light-Activated Content Release from Liposomes
Sarah Leung (2012)
10.1002/adma.201303360
Rational design of polyion complex nanoparticles to overcome cisplatin resistance in cancer therapy.
Xian-Zhu Yang (2014)
10.1016/J.EURPOLYMJ.2015.01.023
Optical properties of amphiphilic copolymer-based self-assemblies
W. Wang (2015)
10.1039/C2SM07388A
pH-responsive liposome-templated polyelectrolyte nanocapsules
Francesca Cuomo (2012)
10.1039/c1cs15166e
Gold nanoparticles in biomedical applications: recent advances and perspectives.
L. Dykman (2012)
10.1038/nnano.2007.165
The need for rules and regulations.
Michael N. Helmus (2007)
10.1016/j.colsurfb.2015.10.014
Magnetic field activated drug release system based on magnetic PLGA microspheres for chemo-thermal therapy.
K. Fang (2015)
Ultrasound-responsive liposomes. Liposomes: Methods and Protocols
S-L Huang
10.1016/j.colsurfb.2008.06.022
Preparation and characterization of complexes of liposomes with gold nanoparticles.
Chie Kojima (2008)
10.1016/J.ADDR.2003.10.038
On the formulation of pH-sensitive liposomes with long circulation times.
S. Simões (2004)
10.1158/0008-5472.CAN-08-2535
Feasibility study of particle-assisted laser ablation of brain tumors in orthotopic canine model.
J. Schwartz (2009)
Reactive oxygen metabolites and upper gastrointestinal diseases.
J. Kountouras (2001)
10.1038/nbt.3330
Principles of nanoparticle design for overcoming biological barriers to drug delivery
E. Blanco (2015)
10.1021/mp100253e
pH-Responsive nanoparticles for drug delivery.
W. Gao (2010)
10.1021/cr900236h
Activatable photosensitizers for imaging and therapy.
J. Lovell (2010)
Liposomal daunorubicin as treatment for Kaposi’s sarcoma
Christin E Petre (2007)
10.1016/j.tibtech.2009.12.007
Frontiers in cancer nanomedicine: directing mass transport through biological barriers.
M. Ferrari (2010)
10.1039/c2cs15308d
Functionalized mesoporous silica materials for controlled drug delivery.
P. Yang (2012)
10.1002/smll.201002185
Controlled release of Fe3O4 nanoparticles in encapsulated microbubbles to tumor cells via sonoporation and associated cellular bioeffects.
F. Yang (2011)
10.1039/c4cc01429d
Smart drug delivery systems: from fundamentals to the clinic.
C. Alvarez-Lorenzo (2014)
10.1016/J.EURPOLYMJ.2011.07.024
Electro-responsive transdermal drug delivery behavior of PVA/PAA/MWCNT nanofibers
Jumi Yun (2011)
10.1016/J.NANTOD.2008.10.011
Biomedical nanoparticle carriers with combined thermal and magnetic responses
Ting-Yu Liu (2009)
10.1016/J.JCONREL.2007.08.006
Tumor pH-responsive flower-like micelles of poly(L-lactic acid)-b-poly(ethylene glycol)-b-poly(L-histidine).
E. Lee (2007)
10.1021/nn501162x
Hyperthermia-mediated local drug delivery by a bubble-generating liposomal system for tumor-specific chemotherapy.
Ko-Jie Chen (2014)
10.1016/j.biomaterials.2013.11.083
A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.
Y. Tian (2014)
10.1016/j.jconrel.2015.03.033
Exosomes as drug delivery vehicles for Parkinson's disease therapy.
M. Haney (2015)
10.1016/j.drudis.2013.04.003
Current status of liposomal porphyrinoid photosensitizers.
P. Skupin-Mrugalska (2013)
10.1039/c3cs35512h
Stimuli-responsive copolymer solution and surface assemblies for biomedical applications.
Elizabeth G Kelley (2013)
10.1002/ADFM.201500745
Stimuli‐Responsive Materials Based on Interpenetrating Polymer Liquid Crystal Hydrogels
Jelle E. Stumpel (2015)
Liposomes: Methods and Protocols, Volume 1: Pharmaceutical Nanocarriers
T. Elbayoumi (2010)
10.1016/j.addr.2012.09.037
Liposomal drug delivery systems: from concept to clinical applications.
T. Allen (2013)
10.1016/j.jconrel.2012.03.020
Doxil®--the first FDA-approved nano-drug: lessons learned.
Y. Barenholz (2012)
10.1038/nmat2986
Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents.
J. Lovell (2011)
10.1021/nn204319b
Macromolecule functionalization of disulfide-bonded polymer hydrogel capsules and cancer cell targeting.
O. Shimoni (2012)
10.1016/j.biomaterials.2014.07.019
High-performance PEGylated Mn-Zn ferrite nanocrystals as a passive-targeted agent for magnetically induced cancer theranostics.
J. Xie (2014)
10.1021/bc1001399
PEG-attached PAMAM dendrimers encapsulating gold nanoparticles: growing gold nanoparticles in the dendrimers for improvement of their photothermal properties.
Yasuhito Umeda (2010)
10.1016/J.ADDR.2006.09.020
Thermo- and pH-responsive polymers in drug delivery.
D. Schmaljohann (2006)
10.1016/j.biomaterials.2010.05.045
Highly temperature-sensitive liposomes based on a thermosensitive block copolymer for tumor-specific chemotherapy.
K. Kono (2010)
10.1088/0957-4484/22/1/015103
Diffusion and clearance of superparamagnetic iron oxide nanoparticles infused into the rat striatum studied by MRI and histochemical techniques.
F. Wang (2011)
10.1002/ADMA.200601817
Thermo and pH Dual‐Responsive Nanoparticles for Anti‐Cancer Drug Delivery
Leyang Zhang (2007)
10.1186/1479-5876-9-47
Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs
Tian Sheng Chen (2010)
10.1039/C4PY01759E
Anthracene functionalized thermosensitive and UV-crosslinkable polymeric micelles
Y. Shi (2015)
10.1021/ja3104268
A general strategy for biocompatible, high-effective upconversion nanocapsules based on triplet-triplet annihilation.
Qian Liu (2013)
10.1016/j.jconrel.2010.10.036
Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study.
M. de Smet (2011)
10.3109/03639041003710151
Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent
Chen Yuejian (2010)
10.1016/j.bbcan.2014.04.005
A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
K. B. Johnsen (2014)
10.1039/c4cs00171k
Stimuli responsive upconversion luminescence nanomaterials and films for various applications.
M. Tsang (2015)
10.1016/j.actbio.2015.08.043
Bio-inspired adhesive catechol-conjugated chitosan for biomedical applications: A mini review.
J. H. Ryu (2015)
10.1042/BJ1240058P
Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases.
G. Gregoriadis (1971)
10.1002/PI.2253
Hydrogels as smart biomaterials
J. Kopeček (2007)
10.1016/j.biomaterials.2009.07.051
Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin.
H. Sun (2009)
10.1021/nl2001499
Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes.
E. Amstad (2011)
10.1016/j.ijpharm.2013.02.020
Towards more effective advanced drug delivery systems.
Daan J.A. Crommelin (2013)
10.1088/0957-4484/26/1/015602
Polymer hydrogel functionalized with biodegradable nanoparticles as composite system for controlled drug delivery.
F. Rossi (2015)
10.1016/j.addr.2012.04.010
Nanoparticles in drug delivery: past, present and future.
P. Couvreur (2013)
10.1038/nmat3776
Stimuli-responsive nanocarriers for drug delivery.
S. Mura (2013)
10.1038/nrd3554
Interfering with pH regulation in tumours as a therapeutic strategy
D. Neri (2011)
10.1103/PHYSREVLETT.40.820
Collapse of Gels and the Critical Endpoint
T. Tanaka (1978)
10.1166/JNN.2015.9803
Effective PEGylation of Fe3O4 Nanomicelles for In Vivo MR Imaging.
L. Song (2015)
10.1021/ja0772086
Enzyme-responsive snap-top covered silica nanocontainers.
Kaushik Patel (2008)
10.1038/483531a
Drug development: Raise standards for preclinical cancer research
C. G. Begley (2012)
10.1186/1556-276X-8-102
Liposome: classification, preparation, and applications
A. Akbarzadeh (2013)
10.1002/anie.201403846
Angiopep-conjugated electro-responsive hydrogel nanoparticles: therapeutic potential for epilepsy.
Xiaoying Ying (2014)
10.1021/acs.biomac.5b01020
Block versus Random Amphiphilic Glycopolymer Nanopaticles as Glucose-Responsive Vehicles.
Qianqian Guo (2015)
10.1016/j.jconrel.2010.07.115
Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery.
A. Klibanov (2010)
10.1016/J.BIOPHA.2006.07.086
Metastatic breast cancer: an updating.
A. Nicolini (2006)
10.1002/chem.201200787
Azobenzene polyesters used as gate-like scaffolds in nanoscopic hybrid systems.
Andrea Bernardos (2012)
10.1039/c0cc01288b
Thermo- and light responsive micellation of azobenzene containing block copolymers.
F. Jochum (2010)
A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals
Y. Wang (2013)
10.1016/J.EURPOLYMJ.2015.01.016
Smart polymers in drug delivery systems on crossroads: Which way deserves following?
M. Hruby (2015)
10.1016/j.jconrel.2009.10.002
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
P. Pradhan (2010)
10.1021/ar800150g
Nanoshell-enabled photothermal cancer therapy: impending clinical impact.
Surbhi Lal (2008)
10.1007/978-1-4614-0881-9
Fundamentals and Applications of Controlled Release Drug Delivery
J. Siepmann (2012)
10.1007/s00280-006-0296-4
In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases
S. Shaffer (2006)
10.1016/j.jconrel.2013.01.001
Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release.
Wei Chen (2013)
10.1007/s11060-012-0880-x
Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series
M. Chamberlain (2012)
10.1021/MA502242V
Redox-Degradable Biocompatible Hyperbranched Polyglycerols: Synthesis, Copolymerization Kinetics, Degradation, and Biocompatibility
Suhyun Son (2015)
10.1016/j.drudis.2015.05.008
Cyclodextrin nanoassemblies: a promising tool for drug delivery.
V. Bonnet (2015)
10.1016/j.jconrel.2016.03.002
Glucose and magnetic-responsive approach toward in situ nitric oxide bubbles controlled generation for hyperglycemia theranostics.
F. Yang (2016)
10.1002/CHIN.201227258
Mesoporous Silica Nanoparticles in Biomedical Applications
Zongxi Li (2012)
10.1126/SCIENCE.364652
Design of liposomes for enhanced local release of drugs by hyperthermia.
M. Yatvin (1978)
10.1002/anie.201311227
Sequential intra-intercellular nanoparticle delivery system for deep tumor penetration.
Caoyun Ju (2014)
Monosaccharide-Responsive Release of Insulin from Polymersomes of Polyboroxole Block Copolymers at Neutral pH
김경택 (2012)
10.1021/ACSMACROLETT.5B00170
Enzyme-Specific Doxorubicin Drug Beacon as Drug-Resistant Theranostic Molecular Probes
Lye Lin Lock (2015)
10.2217/nnm.13.212
pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances.
F. Meng (2014)
10.1016/j.biomaterials.2012.05.062
Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release.
Yuanjia Pan (2012)
10.1002/CHIN.201220214
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
F. Tang (2012)
10.1016/j.jconrel.2012.11.012
Environmental pH-sensitive polymeric micelles for cancer diagnosis and targeted therapy.
G. H. Gao (2013)
10.3390/ma8030832
Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil
M. Subudhi (2015)
10.1016/S0168-3659(03)00303-1
Electro-responsive drug delivery from hydrogels.
S. Murdan (2003)
10.1002/ANIE.200604474
Fibrous aggregation of magnetite nanoparticles induced by a time-varied magnetic field.
J. Sun (2007)
10.4172/2155-952X.1000276
Liposomes for Drug Delivery
Durgavati Yadav (2017)
10.1016/j.addr.2012.07.009
How smart do biomaterials need to be? A translational science and clinical point of view.
B. Holzapfel (2013)
10.1021/ja207150n
Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.
Jin-Zhi Du (2011)
Banghasomes" to liposomes: A memoir of Alec Bangham
D W Deamer (1921)
Injectable nanonetwork for glucosemediated insulin delivery
Z Gu (2013)
10.1002/chem.201500578
Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
Simon Giret (2015)
10.1158/1535-7163.MCT-06-0391
Tumor models for efficacy determination
B. Teicher (2006)
10.1021/JP911933B
Magnetically Sensitive Alginate-Templated Polyelectrolyte Multilayer Microcapsules for Controlled Release of Doxorubicin
J. Liu (2010)
10.1016/j.jconrel.2013.09.023
Rubik-like magnetic nanoassemblies as an efficient drug multifunctional carrier for cancer theranostics.
F. Xiong (2013)
10.1002/ADEM.201080088
Polymers in Drug Delivery—State of the Art and Future Trends
Stefan Grund (2011)
10.2217/nnm.12.87
Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
Suwussa Bamrungsap (2012)
10.1039/c2nr11918h
Conjugation of paclitaxel to iron oxide nanoparticles for tumor imaging and therapy.
D. Liu (2012)
10.1039/B923535N
Liposomes as ‘smart’ pharmaceutical nanocarriers
R. Sawant (2010)
10.1111/j.1463-5224.2010.00775.x
Cellular localization of Visudyne as a function of time after local injection in an in vivo model of squamous cell carcinoma: an investigation into tumor cell death.
Laura D. Barnes (2010)
10.1038/nrd4333
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
V. Torchilin (2014)
10.1002/adma.201103343
Targeting gold nanoshells on silica nanorattles: a drug cocktail to fight breast tumors via a single irradiation with near-infrared laser light.
H. Liu (2012)
10.1021/MZ300662B
Reversible Addition–Fragmentation Chain Transfer Synthesis of a Micelle-Forming, Structure Reversible Thermosensitive Diblock Copolymer Based on the N-(2-Hydroxy propyl) Methacrylamide Backbone
Y. Shi (2013)
10.1002/adma.201202296
Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor.
Y. Yuan (2012)
10.1021/ACSBIOMATERIALS.5B00006
Interfacially Hydrazone Cross-linked Thermosensitive Polymeric Micelles for Acid-Triggered Release of Paclitaxel
Y. Shi (2015)
10.1016/j.jconrel.2010.07.095
Gold-embedded photosensitive liposomes for drug delivery: triggering mechanism and intracellular release.
Lauri Paasonen (2010)
10.1128/AAC.48.3.1047-1050.2004
Comparative Efficacies of Four Amphotericin B Formulations—Fungizone, Amphotec (Amphocil), AmBisome, and Abelcet—against Systemic Murine Aspergillosis
K. Clemons (2004)
Liposomes in drug delivery. Fundamentals and Applications of Controlled Release Drug Delivery: Springer; 2012: p289-328
V. Torchilin (2012)
10.1021/bm400234c
Π-π stacking increases the stability and loading capacity of thermosensitive polymeric micelles for chemotherapeutic drugs.
Y. Shi (2013)
10.1038/nmat2614
Emerging applications of stimuli-responsive polymer materials.
M. C. Stuart (2010)
10.1021/JA076341V
Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging.
Dong-kyu Kim (2007)
10.1016/j.biotechadv.2013.08.002
Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
Jin-Zhi Du (2014)
10.1016/j.actbio.2014.12.001
Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
Pengcheng Yu (2015)



This paper is referenced by
10.1007/s40520-019-01365-6
Nanotechnological approach and bio-inspired materials to face degenerative diseases in aging
A. Tampieri (2019)
10.1016/J.MSEC.2019.03.066
Mesoporous superparamagnetic hydroxyapatite nanocomposite: A multifunctional platform for synergistic targeted chemo-magnetotherapy.
Azadeh Izadi (2019)
10.1021/acsami.7b11423
Sequential Delivery of Doxorubicin and Zoledronic Acid to Breast Cancer Cells by CB[7]-Modified Iron Oxide Nanoparticles.
F. Benyettou (2017)
10.1002/advs.201700339
Radiation‐Sensitive Dendrimer‐Based Drug Delivery System
Szu-Yuan Wu (2018)
10.1039/c8nr05269g
Controllable drug release from nano-layered hollow carrier by non-human enzyme.
Daheui Choi (2018)
10.26452/ijrps.v11i2.1982
Formulation and Evaluation of Bio-adhesive Pulsatile Drug Delivery System of Telmisartan
S. V. Patil (2020)
A metabolomics investigation of a nanogold drug vehicle on experimental animals
S. Bartlett (2019)
10.1016/j.jconrel.2020.10.030
Serum protein-based nanoparticles for cancer diagnosis and treatment.
Haroon Iqbal (2020)
10.1039/c9cc04518j
Tuning the solubility of ionophores: glutathione-mediated transport of chloride ions across hydrophobic membranes.
N. Akhtar (2019)
10.1016/j.jconrel.2017.12.033
Amphiphilic polysaccharides as building blocks for self‐assembled nanosystems: molecular design and application in cancer and inflammatory diseases
Xiaoye Yang (2018)
10.1088/1361-6528/aa839c
Glutathione responsive micelles incorporated with semiconducting polymer dots and doxorubicin for cancer photothermal-chemotherapy.
Zhixiong Cai (2017)
10.1039/C7TB03323K
Progress in internal/external stimuli responsive fluorescent carbon nanoparticles for theranostic and sensing applications.
Z. A. I. Mazrad (2018)
10.2174/1567201816666190123125813
Stimulus Sensitive Smart Nanoplatforms: An Emerging Paradigm for the Treatment of Skin Diseases.
Divya (2019)
10.1002/adfm.201903896
Photoactive Nanocarriers for Controlled Delivery
Qirong Xiong (2020)
10.1038/aps.2017.12
Engineering exosomes as refined biological nanoplatforms for drug delivery
X. Luan (2017)
10.1038/s41413-018-0032-9
Advanced smart biomaterials and constructs for hard tissue engineering and regeneration
K. Zhang (2018)
10.1016/j.jconrel.2018.01.021
Stimuli‐responsive nanocarriers for delivery of bone therapeutics – Barriers and progresses
Pedro Lavrador (2018)
10.2217/nnm-2018-0288
The π-π stacking-guided supramolecular self-assembly of nanomedicine for effective delivery of antineoplastic therapies.
Dongjuan Yang (2018)
10.1016/j.jcis.2017.12.036
Light-sensitive dextran-covered PNBA nanoparticles as triggered drug delivery systems: Formulation, characteristics and cytotoxicity.
Meriem El Founi (2018)
10.1016/j.biomaterials.2020.119979
Yolk-shell nanovesicles endow glutathione-responsive concurrent drug release and T1 MRI activation for cancer theranostics.
D. Liu (2020)
10.2174/1573413715666190328182406
Aggregation-Induced Emission-Active Fluorescent Nanodot as a Potential Photosensitizer for Photodynamic Anticancer Therapy
Y. Zhang (2020)
10.1016/J.MSEC.2020.111536
Recent advances in the redox-responsive drug delivery nanoplatforms: A chemical structure and physical property perspective
S. Mollazadeh (2021)
10.1016/j.ajps.2019.08.003
Tumor microenvironment responsive drug delivery systems
Qunye He (2020)
10.1038/s41392-017-0004-3
Controlled drug delivery vehicles for cancer treatment and their performance
S. Senapati (2018)
10.1007/s12274-016-1322-4
Magnetic iron oxide nanoparticles accelerate osteogenic differentiation of mesenchymal stem cells via modulation of long noncoding RNA INZEB2
Qiwei Wang (2016)
10.3389/fphar.2019.01650
Ultrasound-Responsive Materials for Drug/Gene Delivery
Xiao-wen Cai (2019)
10.1007/s40005-017-0379-8
Progress in topographically defined scaffolds for drug delivery system
M. S. Lee (2017)
Self Regulatory Drug Transport: An Intelligent Drug Delivery System
A. Jain (2018)
10.1080/10610278.2019.1632454
Lipid-DNA conjugates for cell membrane modification, analysis, and regulation
Yousef Bagheri (2019)
10.3390/cancers11060780
Gold as a Possible Alternative to Platinum-Based Chemotherapy for Colon Cancer Treatment
Inés Mármol (2019)
10.1007/978-3-030-01881-8_1
Advances in Drug Delivery Strategies for Microbial Healthcare Products
J. M. Ageitos (2019)
10.2147/IJN.S143776
A nanoliposome-based photoactivable drug delivery system for enhanced cancer therapy and overcoming treatment resistance
Jinjin Shi (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar